Search

everythinglearnresearchcommunity

for

Search:↓

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

New understanding and treatments for hair loss are improving, but more research is needed.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Covid-19 can cause different types of hair loss, which can affect people's mental and social well-being.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Hair loss doesn't affect COVID-19 severity.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

Matriptase is highly active in hair follicles and sebaceous glands, especially during hair growth phases.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

The dermal papilla is crucial for hair growth and health, and understanding it could lead to new hair loss treatments.

Dermal papilla cells are key for hair growth and color, influencing hair type and size, and their interaction with stem cells could help treat hair loss and color disorders.

Corin helps control salt and sweat release in sweat glands.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Testosterone may influence COVID-19 severity and outcomes.

Dermal cells are key in controlling hair growth and could potentially be used in hair loss treatments, but more research is needed to improve hair regeneration methods.

Inhibiting AP1 in mice skin causes structural changes and weakens the skin barrier.

Matriptase is crucial for keeping epithelial tissues healthy and functioning properly.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

A new mutation in the ST14 gene broadens the understanding of ichthyosis-hypotrichosis syndrome.

Early diagnosis and tailored treatments are crucial for managing ichthyosis syndromes with hair abnormalities.

Lack of cystatin M/E causes thin hair and dry skin.